Morgan Stanley Adjusts Price Target on Travelers to $350 From $330

BMO Capital increased its price target for Travelers (NYSE:TRV) to $388 from $379, citing reserve releases and strong margins. The stock trades near its 52-week high. Several analysts have raised their targets following Travelers' strong earnings performance.

JPMorgan raised its price target for Travelers to $379 from $352. The stock has seen a 5-day change of -1.05% and a 1-year change of +32.89%. UBS noted a slowdown in business insurance renewals and weaker margins for the company.

Truist Securities raised its price target for Travelers Companies (TRV) to $435 from $425, citing strong Q3 earnings and increased EPS estimates for 2026 and 2027. The stock is near its 52-week high, up 51% over the past year. Other analysts also adjusted targets, with Evercore ISI at $372 and BMO Capital maintaining a Market Perform rating.

Truist Securities kept a Buy rating on Travelers Companies with a $435 price target, suggesting 11.7% upside from the Oct 16 close. The firm cited strong financial performance, including $9.18 core income per share, and attractive valuation at 12x earnings.

The Travelers Companies Inc (TRV) reported Q3 2026 core income of $1.95B, or $9.18 per diluted share, with a core return on equity of 22.1%. The company saw strong underwriting performance and increased net investment income by 7% to $908M. TRV returned $1.8B to shareholders and faces challenges from catastrophe losses and social inflation. Management expects durable underwriting income and continues to invest in AI and technology.

Travelers reported Q3 2026 earnings of $1.947B, up 4% YoY. However, the average renewal rate increase for domestic business insurance dropped to 0.9%, down from 4.3% a year ago. The combined ratio improved to 86.8%, while the underlying combined ratio rose slightly to 84.1%.